Investor mix
3 investors on record; lead investors include Center for Innovative Technology.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 67% |
| Other / undisclosed | 1 | 33% |
Developer of nucleic acid-based therapies for bacterial infections
3 investors on record; lead investors include Center for Innovative Technology.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 67% |
| Other / undisclosed | 1 | 33% |